# National Cheng-Kung University Hospital

Organization · id `cardio:org-national-cheng-kung-university-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 04zx3rq17](<https://ror.org/04zx3rq17>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 04zx3rq17 by an exact name.

## The registry's words

- Sponsor name: National Cheng-Kung University Hospital
- Sponsor class: OTHER
- ROR name: National Cheng Kung University Hospital

## Connected pages

- Sponsors: The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study) (`cardio:ct-nct01188824`)
- Sponsors: The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis (`cardio:ct-nct02105519`)
- Sponsors: Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease (`cardio:ct-nct02174939`)
- Sponsors: The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke (`cardio:ct-nct02580838`)
- Sponsors: Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation (`cardio:ct-nct02666157`)
- Sponsors: Transcutaneous Laser Therapy in Chronic Kidney Disease (`cardio:ct-nct06855992`)

## Provenance

Content hash: b09bb1dc80dc0c144ee4fee8fb28304d14e2d275899e69bf6d0bad414f7315e5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
